Source:http://linkedlifedata.com/resource/pubmed/id/10917138
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-10-20
|
pubmed:abstractText |
The usefulness of fluorescence in situ hybridization (FISH) analysis to detect minimal residual disease (MRD) in autologous bone marrow and peripheral blood stem-cell harvests has been tested in three patients with hematologic malignancies. Conventional cytogenetics and FISH were used to characterize the leukemic clones identifying the specific chromosomal abnormalities (monosomy 7 in a myelodysplastic patient and trisomy 8 in two acute myeloid leukemic patients). Such analysis was useful to monitor the MRD persistent after treating these patients with intensive chemotherapy. The myelodysplastic patient underwent eight peripheral blood-stem cell harvests in which FISH detected the persistence of monosomy 7 cells, precluding their use for autologous transplantation. This patient relapsed and died. In two acute myeloid leukemia patients who underwent an autologous marrow harvest, FISH did not show a significant proportion of trisomy 8 cells. Nevertheless, autologous transplantation was not performed, owing to an insufficient CD34 cell content in the harvests. One of these patients relapsed with the reappearance of trisomy 8 and died. The other patient, on the contrary, is alive in complete remission 3 years after the bone marrow harvest. The usefulness and applicability of MRD quantification in stem-cell harvests is discussed on the basis of the sensitivity of the methodology applied.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0361-090X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10917138-Adolescent,
pubmed-meshheading:10917138-Adult,
pubmed-meshheading:10917138-Chromosome Aberrations,
pubmed-meshheading:10917138-Female,
pubmed-meshheading:10917138-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10917138-Humans,
pubmed-meshheading:10917138-In Situ Hybridization, Fluorescence,
pubmed-meshheading:10917138-Leukemia, Myeloid,
pubmed-meshheading:10917138-Leukemia, Myeloid, Acute,
pubmed-meshheading:10917138-Male,
pubmed-meshheading:10917138-Middle Aged,
pubmed-meshheading:10917138-Myelodysplastic Syndromes,
pubmed-meshheading:10917138-Neoplasm, Residual,
pubmed-meshheading:10917138-Tissue and Organ Harvesting,
pubmed-meshheading:10917138-Transplantation, Autologous
|
pubmed:year |
2000
|
pubmed:articleTitle |
Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
|
pubmed:affiliation |
Department of Haematology, Clínica Puerta de Hierro, Spain.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|